$UAMY

US Antimony stock gains after $100M buyback approval

United States Antimony (UAMY) shares rose 1.9% in premarket trading after the company announced a $100M share repurchase program. The board approved the buyback, which has no expiration date. CEO Gary Evans cited undervaluation and future potential. UAMY produces critical minerals, including antimony.

Original reporting
Published Aug 19, 2026, 12:32 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 19, 2026, 12:52 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$UAMY
Bullish
high confidence
Mentioned
$UAMY
Relevance
7/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$UAMYBullishHigh
01

Why it matters

The buyback signals confidence in valuation and may attract short‑term buyers, but long‑term performance depends on antimony market fundamentals.

02

Market read

The announcement drove a 1.9% pre‑market gain, indicating immediate market reaction.

03

What to watch

Potential financing constraints and commodity price volatility.

Relevance 7/10Novelty 8/10Timing: premarket today

Background

UAMY is the only fully integrated antimony producer outside China and Russia, operating in the U.S., Canada, and Mexico.

Company-level read

Ticker impact

$UAMYBullishHigh confidence
Context

Company announced a $100 million share repurchase program approved by its board.

Expected impact

Potential short‑term upside as demand for shares rises.

Evidence & confidence

The program size is material for a micro‑cap and the announcement came pre‑market, prompting a 1.9% rise.

Market effects

May boost sentiment for the broader critical‑minerals sector.

Limited to U.S. and North‑American investors focused on mining stocks.

Low global impact; primarily a micro‑cap specific move.

Counterpoint

Buyback could be a defensive move masking underlying demand weakness.

Key entities

  • Gary C. Evans

    Chairman and CEO of United States Antimony Corporation.

Related articles

$UAMYMed

US Antimony (UAMY) Q2 2026 Earnings Call Transcript

US Antimony (UAMY) reported Q2 2026 revenue of $7.9M, down 25% YoY due to lower antimony prices but up 17% sequentially. Antimony revenue fell 39% YoY to $5.9M, while zeolite revenue surged 110% YoY to $1.9M. Gross profit declined to $0.6M from $2.8M YoY. The company has $62.2M in liquidity and is executing a $245M DLA contract. CEO Evans cited Chinese price manipulation for lower antimony prices.

$UAMYMedAI 8/10

UNITED STATES ANTIMONY CORP (UAMY): Results of Operations and Financial Condition

UNITED STATES ANTIMONY CORP (UAMY) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 tm2622899d2_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Transcript of United States Antimony Corp. US Antimony Second Quarter 2026 Financial and Operational Results Webcast August 11, 2026 Participants Gary Evans - CEO & Chairman, United States Antimony Corporation Shawn Winkl

$UAMYHighAI 9/10

Why United States Antimony Stock Is Plummeting This Week

United States Antimony (UAMY) shares fell about 22% week to date after the company reported Q2 results and cut full-year sales guidance. Q2 net income was $0.1M on $7.93M sales, with revenue down nearly 25% YoY and missing analyst expectations. Full-year sales guidance was reduced to $60M-$75M versus prior ~$125M and Street ~$115.3M.